Profiles of circulating inflammatory- and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E-coli O157 infection

被引:40
作者
Murata, A
Shimazu, T
Yamamoto, T
Taenaka, N
Nagayama, K
Honda, T
Sugimoto, H
Monden, M
Matsuura, N
Okada, S
机构
[1] Osaka Univ, Sch Med, Dept Surg 2, Suita, Osaka 565, Japan
[2] Osaka Univ, Sch Med, Dept Traumatol, Suita, Osaka 565, Japan
[3] Osaka Univ, Sch Med, Dept Pediat, Suita, Osaka 565, Japan
[4] Osaka Univ, Sch Med, Intens Care Unit, Suita, Osaka 565, Japan
[5] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan
[6] Osaka Univ, Sch Allied Hlth Sci, Dept Pathol, Suita, Osaka 565, Japan
关键词
cytokine; E-coli O157; haemolytic uraemic syndrome; inflammation; interleukin; 10;
D O I
10.1006/cyto.1997.0329
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The systemic inflammatory response to Escherichia coli O157 infection was studied from the profiles of circulating inflammatory and anti-inflammatory cytokines, Twelve patients transferred sequentially to our hospital for the intensive care with acute illness due to Escherichia coli O157 infection and the possible form of haemolytic uraemic syndrome were included in this study, Increased circulating concentrations of tumour necrosis factor, interleukin 6, interleukin 8, granulocyte colony-stimulating factor, and interleukin 10 were found in patients with various stages of this infection and haemolytic uraemic syndrome, Especially, the degree of the increase of circulating interleukin 10 in those who had a typical signs of haemolytic uraemic syndrome was higher than those of other inflammatory cytokines. Two groups of E, coli infection could be classified into one with a typical haemolytic uraemic syndrome and the other with atypically bacteremic state over haemolytic uraemic syndrome according to these cytokine levels. (C) 1998 Academic Press.
引用
收藏
页码:544 / 548
页数:5
相关论文
共 17 条
[1]   Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world [J].
Armstrong, GL ;
Hollingsworth, J ;
Morris, JG .
EPIDEMIOLOGIC REVIEWS, 1996, 18 (01) :29-51
[2]   INTERLEUKIN-8 AND POLYMORPHONEUTROPHIL LEUKOCYTE ACTIVATION IN HEMOLYTIC UREMIC SYNDROME OF CHILDHOOD [J].
FITZPATRICK, MM ;
SHAH, V ;
TROMPETER, RS ;
DILLON, MJ ;
BARRATT, TM .
KIDNEY INTERNATIONAL, 1992, 42 (04) :951-956
[3]  
FORSYTH KD, 1989, LANCET, V2, P411
[4]   ESCHERICHIA-COLI CYTOTOXINS AND ENTEROTOXINS [J].
GYLES, CL .
CANADIAN JOURNAL OF MICROBIOLOGY, 1992, 38 (07) :734-746
[5]   A REPORTER TRANSGENE INDICATES RENAL-SPECIFIC INDUCTION OF TUMOR-NECROSIS-FACTOR (TNF) BY SHIGA-LIKE TOXIN - POSSIBLE INVOLVEMENT OF TNF IN HEMOLYTIC-UREMIC SYNDROME [J].
HAREL, Y ;
SILVA, M ;
GIROIR, B ;
WEINBERG, A ;
CLEARY, TB ;
BEUTLER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (05) :2110-2116
[6]   Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura [J].
Karpman, D ;
Andreasson, A ;
Thysell, H ;
Kaplan, BS ;
Svanborg, C .
PEDIATRIC NEPHROLOGY, 1995, 9 (06) :694-699
[7]   INTERLEUKIN-10 REDUCES MORTALITY FROM SEVERE PERITONITIS IN MICE [J].
KATO, T ;
MURATA, A ;
ISHIDA, H ;
TODA, H ;
TANAKA, N ;
HAYASHIDA, H ;
MONDEN, M ;
MATSUURA, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1336-1340
[8]  
KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452
[9]   INTERLEUKIN-10-DEFICIENT MICE DEVELOP CHRONIC ENTEROCOLITIS [J].
KUHN, R ;
LOHLER, J ;
RENNICK, D ;
RAJEWSKY, K ;
MULLER, W .
CELL, 1993, 75 (02) :263-274
[10]   TUMOR-NECROSIS-FACTOR CONCENTRATIONS IN HEMOLYTIC-UREMIC SYNDROME PATIENTS AND CHILDREN WITH BLOODY DIARRHEA IN ARGENTINA [J].
LOPEZ, EL ;
CONTRINI, MM ;
DEVOTO, S ;
DEROSA, MF ;
GRANA, MG ;
GENERO, MH ;
CANEPA, C ;
GOMEZ, HF ;
CLEARY, TG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (07) :594-598